Schmidt & Clark | A National Law Firm

Injured by Trasylol Side Effects?

Send to Friend | Bookmark | Live Chat

Trasylol Resources

Trasylol Side Effects

S&C Related Contents

>> Trasylol

Trasylol Recall

Trasylol Heart Surgery

FDA Trasylol Warning & Recall Information

11/5/07: FDA Requests Marketing Suspension of Trasylol

12/15/06: FDA Trasylol Label Change and Warning

12/15/06: MedWatch Trasylol Adverse Event Report

Must Read: FDA Trasylol Resource Page

Trasylol use linked to increased risk of death, kidney or renal failure, heart attacks, strokes and encephalopathy among heart surgery patients. There may have been approximately 22,000 deaths associated with the use of Trasylol.

How much did Bayer know? And why did it take Bayer and the U.S. Food and Drug Administration nearly two years to take the drug off the market after major studies revealed the danger? Two years - during which it's estimated Trasylol was contributing to the loss of one thousand lives a month.

CBS 60 Minutes - Trasylol may have caused over 22,000 deaths

Feb. 17, 2008 --CBS 60 minutes video titled, "One Thousand Lives A Month" Researcher Estimates 22,000 Lives Could Have Been Saved Had Trasylol Been Pulled Earlier

Watch the full length video below.

If you or a loved one have undergone heart surgery and subsequently developed kidney or renal failure and are now undergoing dialysis treatments or have passed away, you should contact us immediately by using the form below or dialing (866) 588-0600. You may be entitled to compensation by filing a Trasylol lawsuit and we can help.

Schmidt & Clark has been actively pursuing Trasylol side effect cases since 2006. The Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Trasylol lawsuits. We are handling individual litigation nationwide and currently accepting new Trasylol cases in all 50 states.

Learn More: Trasylol Recall

11/5/07: FDA Requests Marketing Suspension of Trasylol

12/15/06: FDA Trasylol Label Change and Warning

12/15/06: MedWatch Trasylol Adverse Event Report

Must Read: FDA Trasylol Resource Page

FDA Announces Suspension of Trasylol

November 5, 2007 --The U.S. Food and Drug Administration (FDA) today announced that, at the agency's request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.

What is Trasylol?

Trasylol (Generic: aprotinin) is an injectable prescription drug which inhibits certain enzymes that increase the risk of bleeding during surgery and aids the body's ability to prevent bleeding.

Normally, the drug is given to patients undergoing heart bypass surgery to control blood loss, but has also been used in other surgeries, such as hip replacement surgery.

Trasylol is manufactured by Bayer Pharmaceuticals Corporation and was approved by the Food and Drug Administration in December 1993 to reduce bleeding and the need for blood transfusion in patients undergoing heart surgery.

What is the problem?

Beaking News: Recently, CBS 60 minutes released a segment titled, "One Thousand Lives A Month" Researcher Estimates 22,000 Lives Could Have Been Saved Had Trasylol Been Pulled Earlier.

Previous to this, on November 5, 2007 Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.

Previously, The New England Journal of Medicine recently found the use of Trasylol doubled the risk of kidney failure, increased the chance of heart attack or heart failure by 55% and resulted in a 181% increase in the risk of stroke. Another study confirmed the increased risk of kidney failure with the use of Trasylol.

The lead author of the New England Journal of Medicine study, and his colleagues estimated that over 11,000 patients a year may now be on dialysis as a result of Trasylol use.

In an interview the Author said, Trasylol is "Vioxx 2." Vioxx was removed from the market in 2004 due to an increase of heart attacks. The author also said that the frequency of adverse events from Trasylol were "far greater" than was seen with Vioxx.

Do I have a Trasylol Lawsuit?

The Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Trasylol lawsuits. We are handling individual litigation nationwide and currently accepting new Trasylol cases in all 50 states.

Again, If you or a loved one have undergone heart surgery and subsequently developed kidney or renal failure and are now undergoing dialysis treatments or have passed away, you should contact us immediately by using the form below or dialing (866) 588-0600. You may be entitled to compensation by filing a Trasylol lawsuit and we can help.

Attention Attorneys: We do not publish prior verdict/settlements. If you are an attorney and would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.

Free Confidential Case Evaluation

Toll Free 24 hrs/day (866) 588-0600

Secure 128-bit SSL Encrypted Email Communication Secure 128-bit SSL Encrypted Email Communication - Click Here.

Secure 128-bit SSL Encrypted Email Communication Secure 1024-bit SSL Encrypted Live Chat Communication - Click Here.

Fields Marked with * are required= Required Field

Trasylol Side Effects & Lawsuit News (National)

LegalView Updates Trasylol Practice Area in Light of New Reports ... - PR.com
LegalView.com updated its Trasylol information portal after new reports detailing the drugs allegedly dangerous side effects. Bayer AG's Trasylol (Aprotinin) is used during heart surgery procedures to control blood clotting, but is allegedly ...

American Heart Association Advisory: Bayer Suspends Marketing of ... - PR Newswire
DALLAS, Nov. 5 /PRNewswire-USNewswire/ -- On Monday the FDA announced that Bayer Pharmaceuticals Corp. has voluntarily agreed to stop marketing aprotinin (Trasylol) due to concerns raised by a Canadian study and other investigations that suggest ...

60 Minutes - CBS News
Pat Tillman, Exonerated, Paul Farmer |  05/04/2008 The Dallas County District Attorney's Office and the Innocence Project of Texas work together to re-examine cases; Mary Tillman talks about the case of her son, Pat, killed by friendly fire; Dr ...

Up Next - CBS News
EXONERATED - The Dallas County District Attorney?s office and the Innocence Project of Texas have joined forces to re-examine cases and have freed several inmates so far, including James Woodard , who spent 27 years in jail. Scott Pelley reports ...

Click here to view the list of recent Press Releases from LegalView - PR.com
LegalView recently updated its Heparin information portal on the latest news regarding the contaminated batch of Heparin, which may have sickened hundreds and caused the death of up to 90 individuals. U.S. officials have sourced the contamination to ...

Bayer CEO says faces 78 Trasylol lawsuits in U.S. - Reuters
COLOGNE, Germany (Reuters) - Germany's Bayer AG is facing 78 lawsuits in the United States linked to its Trasylol drug used to stem bleeding during open heart surgery, its chief executive said on Friday. "We are not aware of any lawsuit outside the ...

Lawsuits seek damages from Bayer over anti-bleeding drug - Miami Herald
Eight lawsuits filed in a Florida federal court are seeking damages from Bayer AG over a controversial anti-bleeding drug. The lawsuits involving the drug Trasylol were filed in federal court in West Palm Beach by St. Louis-based law firm Carey ...

Trasylol Pulled From Worldwide Market - MedicineNet.com
The FDA cannot identify a patient population in which the use of Trasylol (aprotinin) outweighs the risk, Dr. John K. Jenkins, director of the FDA's Office of New Drugs, said at an early morning news conference Monday. However, he added, "the ...

More Evidence of Danger From Heart Surgery Drug - MedicineNet.com
WEDNESDAY, Feb. 20 HealthDay News) -- Two new studies confirm an increased incidence of death and kidney damage among people given Trasylol (aprotinin), a drug used to reduce bleeding during coronary artery bypass surgeries. The studies suggest the ...

60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder ... - Yahoo Finance
BIRMINGHAM, Ala., Feb. 15 /PRNewswire/ -- Cory Watson Crowder & DeGaris, P.C. ( www.cwcd.com ), has filed lawsuits against Bayer AG on behalf of plaintiffs throughout the United States, who allegedly suffered permanent kidney damage after being given ...



Toll Free (866) 588-0600


The Best Lawyers in America

Million Dollar Advocates Forum

People Over Profits - Attorney, Lawyer Group

American Association for Justice

Lexic Nexis Peer Review Rated Attorneys and Lawyers

 

ATLA Attorney, Atla Lawyer

 

Leading Plaintiff's Lawyers in America